Lineage switch in a pediatric patient with KMT2A-MLLT3 from acute megakaryoblastic leukemia to T cell acute lymphoblastic leukemia at the fourth relapse after allo-HSCT: with literature review

被引:0
作者
Li Gao
Jun Lu
Jie Li
Yixin Hu
Ye Lu
Weiwei Du
Shaoyan Hu
机构
[1] Children’s Hospital of Soochow University,Department of Hematology and Oncology
来源
International Journal of Hematology | 2023年 / 117卷
关键词
Lineage switch; Acute megakaryoblastic leukemia; Relapse; T cell acute lymphoblastic leukemia;
D O I
暂无
中图分类号
学科分类号
摘要
We present a patient with acute megakaryoblastic leukemia (AMKL) harboring KMT2A-MLLT3 that converted to T cell acute lymphoblastic leukemia (T-ALL) at her fourth relapse. A 4-year-old girl developed AMKL with multiple swollen lymph nodes. She exhibited several recurrences in the bone marrow and died of septic shock after her fourth relapse. Bone marrow cells at the initial diagnosis and at all four relapses had the same KMT2A-MLLT3 fusion transcript. She also developed a somatic mutation (c.7177C > T p.Q2393X) of NOTCH1 at the fourth relapse. This sequential phenotypic and cytogenetic study may yield valuable insights into the mechanism of AMKL to T-ALL lineage switch and possible implications for treatment selection.
引用
收藏
页码:781 / 785
页数:4
相关论文
共 102 条
[1]  
Schweitzer J(2015)Improved outcome of pediatric patients with acute megakaryoblastic leukemia in the AML-BFM 04 trial Ann Hematol 94 1327-1336
[2]  
Zimmermann M(2015)Heterogeneous cytogenetic subgroups and outcomes in childhood acute megakaryoblastic leukemia: a retrospective international study Blood 126 1575-1584
[3]  
Rasche M(2019)Outcome of childhood acute megakaryoblastic leukemia: children’s cancer hospital Egypt 57357 experience Clin Lymphoma Myeloma Leuk 19 e142-e152
[4]  
von Neuhoff C(2018)The comparative sensitivity of immunohistochemical markers of megakaryocytic differentiation in acute megakaryoblastic leukemia Am J Clin Pathol 150 461-467
[5]  
Creutzig U(2020)A retrospective study of myeloid leukaemia in children with Down syndrome in Ireland Ir J Med Sci 189 979-984
[6]  
Dworzak M(2019)Molecular features, prognosis, and novel treatment options for pediatric acute megakaryoblastic leukemia Expert Rev Hematol 12 285-293
[7]  
Inaba H(2017)Prognostic significance of flow-cytometry evaluation of minimal residual disease in children with acute myeloid leukaemia treated according to the AIEOP-AML 2002/01 study protocol Br J Haematol 177 116-126
[8]  
Zhou Y(2017)Acute megakaryoblastic leukemia (excluding Down syndrome) remains an acute myeloid subgroup with inferior outcome in the French ELAM02 trial Pediatr Hematol Oncol 34 425-427
[9]  
Abla O(2016)Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: a retrospective intergroup study Blood 127 3424-3430
[10]  
Adachi S(2012)Lineage switch in childhood acute leukemia: an unusual event with poor outcome Am J Hematol 87 890-897